These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 24632699

  • 21. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
    Raman V, Kim J, Sharkey A, Chatila T.
    Pediatr Infect Dis J; 2001 Jun; 20(6):635-7. PubMed ID: 11419513
    [Abstract] [Full Text] [Related]

  • 22. A case of Kawasaki disease complicated by acute disseminated encephalitis.
    Furui S, Seki M, Minami T, Goto M, Yamagata T.
    Pediatr Int; 2020 Jul; 62(7):872-873. PubMed ID: 32588500
    [No Abstract] [Full Text] [Related]

  • 23. Refractory pneumonia and high fever.
    Falcini F, Vitale A, La Torre F, Conti G, Fede C, Calcagno G.
    Lancet; 2009 May 23; 373(9677):1818. PubMed ID: 19465237
    [No Abstract] [Full Text] [Related]

  • 24. [Macrophage activation syndrome in 2 cases with Kawasaki disease: clinical analysis and review of literature].
    Hu XF, Wang HW, Shi H.
    Zhonghua Er Ke Za Zhi; 2006 Nov 23; 44(11):833-5. PubMed ID: 17274871
    [No Abstract] [Full Text] [Related]

  • 25. Painful jaundice revealing Kawasaki disease in a young man.
    Granel B, Serratrice J, Ene N, Igual JP, Habib G, Disdier P, Weiller PJ.
    J Gastroenterol Hepatol; 2004 Jun 23; 19(6):713-5. PubMed ID: 15151633
    [Abstract] [Full Text] [Related]

  • 26. Acute respiratory distress syndrome in a child with Kawasaki disease.
    Palmer AL, Walker T, Smith JC.
    South Med J; 2005 Oct 23; 98(10):1031-3. PubMed ID: 16295819
    [Abstract] [Full Text] [Related]

  • 27. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab.
    O'connor MJ, Saulsbury FT.
    Clin Pediatr (Phila); 2007 May 23; 46(4):345-8. PubMed ID: 17475994
    [Abstract] [Full Text] [Related]

  • 28. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun 23; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 29. A case of macrophage activation syndrome developing in a patient with chronic granulomatous disease-associated colitis.
    Akagi K, Kawai T, Watanabe N, Yokoyama M, Arai K, Harayama S, Oana S, Onodera M.
    J Pediatr Hematol Oncol; 2014 Apr 23; 36(3):e169-72. PubMed ID: 23652865
    [Abstract] [Full Text] [Related]

  • 30. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.
    Lin Y, Shi L, Deng YJ, Liu Y, Zhang HW.
    Medicine (Baltimore); 2019 Jan 23; 98(4):e14203. PubMed ID: 30681594
    [Abstract] [Full Text] [Related]

  • 31. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
    Wallace CA, French JW, Kahn SJ, Sherry DD.
    Pediatrics; 2000 Jun 23; 105(6):E78. PubMed ID: 10835091
    [Abstract] [Full Text] [Related]

  • 32. Retropharyngeal involvement in Kawasaki disease--a report of four patients with retropharyngeal edema verified by magnetic resonance imaging.
    Puhakka L, Saat R, Klockars T, Kajosaari L, Salo E, Nieminen T.
    Int J Pediatr Otorhinolaryngol; 2014 Oct 23; 78(10):1774-8. PubMed ID: 25081603
    [Abstract] [Full Text] [Related]

  • 33. Refractory Kawasaki disease.
    Freeman AF, Shulman ST.
    Pediatr Infect Dis J; 2004 May 23; 23(5):463-4. PubMed ID: 15131473
    [No Abstract] [Full Text] [Related]

  • 34. [Steroid pulse therapy].
    Miura M.
    Nihon Rinsho; 2014 Sep 23; 72(9):1631-5. PubMed ID: 25518414
    [Abstract] [Full Text] [Related]

  • 35. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.
    Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW.
    J Pediatr; 2011 Apr 23; 158(4):644-649.e1. PubMed ID: 21129756
    [Abstract] [Full Text] [Related]

  • 36. Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
    Almeida B, Gleeson P, Chawla K, Brogan P.
    Br J Hosp Med (Lond); 2012 Feb 23; 73(2):C26-8. PubMed ID: 22504712
    [Abstract] [Full Text] [Related]

  • 37. Extremely refractory Kawasaki disease with disseminated intravascular coagulation.
    Koh YK, Lee JH, Park YB.
    Cardiol Young; 2017 Jul 23; 27(5):1004-1007. PubMed ID: 28264746
    [Abstract] [Full Text] [Related]

  • 38. Typical Kawasaki disease with atypical pneumonia: a paediatric case report.
    Maggio MC, Cimaz R, Failla MC, Dones P, Corsello G.
    Scand J Rheumatol; 2021 May 23; 50(3):248-249. PubMed ID: 32804000
    [No Abstract] [Full Text] [Related]

  • 39. [Prednisolone therapy for Kawasaki disease].
    Kobayashi T, Kobayashi T, Arakawa H.
    Nihon Rinsho; 2014 Sep 23; 72(9):1623-8. PubMed ID: 25518413
    [Abstract] [Full Text] [Related]

  • 40. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM.
    Clin Rheumatol; 2004 Feb 23; 23(1):11-3. PubMed ID: 14749974
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.